VIRIDIAN THERAPEUTICS
Viridian Therapeutics is a biotechnology company advancing new treatments for patients with diseases that are underserved by today’s therapies. Viridian is developing multiple product candidates to treat patients who suffer from thyroid eye disease (TED), a debilitating orphan disease, and has early-stage programs focused on other targets and indications.
VIRIDIAN THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Therapeutics
Founded:
2007-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Website Url:
http://www.viridiantherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
+1 303 531 5952
Email Addresses:
[email protected]
Total Funding:
346.7 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS Google Google Maps API Google Cloud Cloudflare Hosting Network Solutions DNS
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2020-10-28 | Viridian Therapeutics | Viridian Therapeutics acquired by Viridian Therapeutics | N/A |
2016-11-02 | Signal Genetics | Signal Genetics acquired by Viridian Therapeutics | 60 M USD |
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Viridian Therapeutics
Remeditex Ventures
Remeditex Ventures investment in Series C - Viridian Therapeutics
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - Viridian Therapeutics
Atlas Venture
Atlas Venture investment in Series C - Viridian Therapeutics
MP Healthcare Venture Management
MP Healthcare Venture Management investment in Series C - Viridian Therapeutics
Brace Pharma
Brace Pharma investment in Series C - Viridian Therapeutics
JAFCO
JAFCO investment in Series C - Viridian Therapeutics
Boulder Ventures
Boulder Ventures investment in Series C - Viridian Therapeutics
MRL Ventures Fund
MRL Ventures Fund investment in Series C - Viridian Therapeutics
Remeditex Ventures
Remeditex Ventures investment in Series B - Viridian Therapeutics
Key Employee Changes
Official Site Inspections
http://www.viridiantherapeutics.com Semrush global rank: 5.02 M Semrush visits lastest month: 1.66 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago